Acurx Pharmaceuticals, Inc. (ACXP)
NASDAQ: ACXP · Real-Time Price · USD
0.4730
-0.0260 (-5.21%)
At close: Jul 11, 2025, 4:00 PM
0.4605
-0.0125 (-2.64%)
After-hours: Jul 11, 2025, 7:57 PM EDT

Acurx Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Selling, General & Admin
7.438.78.537.3410.782.4
Upgrade
Research & Development
4.455.46.044.752.032.2
Upgrade
Operating Expenses
11.8714.114.5812.0912.814.6
Upgrade
Operating Income
-11.87-14.1-14.58-12.09-12.81-4.6
Upgrade
EBT Excluding Unusual Items
-11.87-14.1-14.58-12.09-12.81-4.6
Upgrade
Other Unusual Items
----0.07-
Upgrade
Pretax Income
-11.87-14.1-14.58-12.09-12.75-4.6
Upgrade
Net Income
-11.87-14.1-14.58-12.09-12.75-4.6
Upgrade
Net Income to Common
-11.87-14.1-14.58-12.09-12.75-4.6
Upgrade
Shares Outstanding (Basic)
1716131196
Upgrade
Shares Outstanding (Diluted)
1716131196
Upgrade
Shares Change (YoY)
26.96%27.56%17.15%26.72%37.88%30.29%
Upgrade
EPS (Basic)
-0.69-0.87-1.15-1.12-1.49-0.74
Upgrade
EPS (Diluted)
-0.69-0.87-1.15-1.12-1.49-0.74
Upgrade
EBIT
-11.87-14.1-14.58-12.09-12.81-4.6
Upgrade
Updated May 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q